| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01CE01 |
| UNII: | 7M7YKX2N15 |
| InChI Key | UCFGDBYHRUNTLO-QHCPKHFHSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H23N3O5 |
| Molecular Weight | 421.45 |
| AlogP | 1.85 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 104.89 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 31.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | -0.880 | - | EST |
| Atmospheric OH Rate Constant | 2.92E-10 | cm3/molecule-sec | EST |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 1521.1 | - | - | - | |
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Enzyme
Isomerase
|
54-71.3 | 21-22880 | 26.5 | - | 31.98-92.85 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -45.36--4.69 | |
|
Transcription factor
|
12 | 60 | - | - | 82.8 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 17.3 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 61000 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 1300 | - | - | 50 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ganglioneuroblastoma | 3 | D018305 | ClinicalTrials |
| Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Retinoblastoma | 3 | D012175 | ClinicalTrials |
| Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
| Small Cell Lung Carcinoma | 3 | D055752 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Neuroblastoma | 3 | D009447 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Uterine Neoplasms | 2 | D014594 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial | 2 | D000077216 | ClinicalTrials |
| Sarcoma, Ewing | 2 | D012512 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Rhabdomyosarcoma | 2 | D012208 | ClinicalTrials |
| Medulloblastoma | 2 | D008527 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Mediastinal Neoplasms | 2 | D008479 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Wilms Tumor | 2 | D009396 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Wilms Tumor | 2 | D009396 | ClinicalTrials |
| Colonic Neoplasms | 2 | D003110 | ClinicalTrials |
| Sarcoma, Clear Cell | 1 | D018227 | ClinicalTrials |
| Carcinoma, Small Cell | 1 | D018288 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Paraganglioma | 1 | D010235 | ClinicalTrials |
| Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
| Meningitis, Aseptic | 1 | D008582 | ClinicalTrials |
| Desmoplastic Small Round Cell Tumor | 1 | D058405 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Liposarcoma, Myxoid | 1 | D018208 | ClinicalTrials |
| Oligodendroglioma | 1 | D009837 | ClinicalTrials |
| Fibrosarcoma | 1 | D005354 | ClinicalTrials |
| Astrocytoma | 1 | D001254 | ClinicalTrials |
| Oligodendroglioma | 1 | D009837 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Genital Neoplasms, Female | 1 | D005833 | ClinicalTrials |
| Neoplasms, Plasma Cell | 1 | D054219 | ClinicalTrials |
| Meningeal Neoplasms | 1 | D008577 | ClinicalTrials |
| Fibroma | 1 | D005350 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
| Histiocytoma | 1 | D051642 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 1 | D045169 | ClinicalTrials |
| Myoepithelioma | 1 | D009208 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 123948-87-8 |
| ChEBI | 63632 |
| ChEMBL | CHEMBL84 |
| DrugBank | DB01030 |
| DrugCentral | 2707 |
| EPA CompTox | DTXSID3042685 |
| FDA SRS | 7M7YKX2N15 |
| Human Metabolome Database | HMDB15164 |
| Guide to Pharmacology | 7101 |
| KEGG | C11158 |
| PDB | TTC |
| PharmGKB | PA451729 |
| PubChem | 60700 |
| SureChEMBL | SCHEMBL3836 |
| ZINC | ZINC000001611274 |